Manhattan Behavioral Medicine — New York, New York

Manhattan Behavioral Medicine is a clinical research site located in New York, New York, United States 10036.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Manhattan Behavioral Medicine has participated in 26 clinical trials with 2 currently active.

Therapeutic areas: Migraine, Migraine With Aura, Migraine Without Aura.

Sponsors: Satsuma Pharmaceuticals, Inc., Naurex, Inc, an affiliate of Allergan plc, Shire.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Manhattan Behavioral Medicine?

Manhattan Behavioral Medicine has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Manhattan Behavioral Medicine conducted?

Manhattan Behavioral Medicine has 26 clinical trials on record, with 2 currently active. Their work covers Migraine, Migraine With Aura, Migraine Without Aura.

Is Manhattan Behavioral Medicine accredited by Crixeo Health?

Yes — Manhattan Behavioral Medicine holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Manhattan Behavioral Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.